Back to search
FDAFDA · Food and drugs·Recall number D-0246-2022

LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3

Published November 24, 2021 · Recall initiated: October 1, 2021

Summary

FDA records drug Class I recall D-0246-2022, published November 24, 2021 and initiated October 1, 2021. Recalling firm: Bayer Healthcare Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 2,817,468 cans; Lot: Lot # TN008D3, TN009K7, Exp 5/31/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: presence of benzene

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bayer Healthcare Pharmaceuticals Inc.
Distributor
Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.
Lot
Lot # TN008D3, TN009K7, Exp 5/31/2023.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3 recalled?

Yes. FDA published recall D-0246-2022 on November 24, 2021. Reported hazard: Chemical Contamination: presence of benzene

What should I do if I have this product?

Voluntary: Firm initiated · Press Release